Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

This page is alzhub.org's plain-English summary of a published study, not the paper itself. It is generated from the record we hold for this study, sourced and linked below — check the original for the full text and methods.

✓ Peer-reviewed alzhub usefulness score 41 out of 100. Getting a diagnosis

Topic: Risk, prevention and care in population studies

Overall, the combined features model achieved a higher discrimination accuracy than models with single feature sets alone. Specifically, the model’s ability to differentiate MCI from healthy individuals, including young adults, reached an average accuracy of 74.62%. For distinguishing MCI from elderly controls, the model’s accuracy averaged 66.50%. Results show that a multimodal model significantly outperforms single-feature models in identifying MCI, highlighting the potential of eye-tracking for early detection. These findings suggest that integrating multimodal data can enhance the effectiveness of MCI auxiliary identification, providing a novel potential pathway for community-based early detection efforts.

Cite this study APA, Vancouver, BibTeX · download .bib or .ris

APA 7th

Li, N., Wang, Z., Ren, W., Zheng, H., Liu, S., Zhou, Y., et al. (2025). Enhancing Mild Cognitive Impairment Auxiliary Identification Through Multimodal Cognitive Assessment with Eye Tracking and Convolutional Neural Network Analysis. Biomedicines. https://doi.org/10.3390/biomedicines13030738

Vancouver

Li N, Wang Z, Ren W, Zheng H, Liu S, Zhou Y, et al. Enhancing Mild Cognitive Impairment Auxiliary Identification Through Multimodal Cognitive Assessment with Eye Tracking and Convolutional Neural Network Analysis. Biomedicines. 2025. doi:10.3390/biomedicines13030738. PMID: 40149714.

BibTeX

@article{li2025-40149714,
  author  = {Li, Na and Wang, Ziming and Ren, Wen and Zheng, Hong and Liu, Shuai and Zhou, Yi and Ju, Kang and Chen, Zhongting},
  title   = {{Enhancing Mild Cognitive Impairment Auxiliary Identification Through Multimodal Cognitive Assessment with Eye Tracking and Convolutional Neural Network Analysis}},
  journal = {Biomedicines},
  year    = {2025},
  doi     = {10.3390/biomedicines13030738},
  pmid    = {40149714},
  url     = {https://doi.org/10.3390/biomedicines13030738}
}

Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record names 8 authors; APA and Vancouver show the first six, BibTeX and the downloads carry all of them. Check the citation against the original before you use it.

Key findings

Why it matters

This study found that a multimodal model combining eye tracking and convolutional neural network analysis identified mild cognitive impairment with an average accuracy of 74.62% against healthy individuals including young adults, and 66.50% against elderly controls. It is about an auxiliary identification method and does not treat, cure or prevent Alzheimer's disease.

Study details

How this study scored 41/100
How this study's score is builtJournal tier 7 of 10; Journal's citation record 1 of 4; Study design 0 of 12; Strength of evidence 1 of 5; Peer-review validation 10 of 10; How recent 4 of 5; Sample size 2 of 4; Effect reported 2 of 3; Studied in people 3 of 3; Randomised / blinded 0 of 2; Times cited 1 of 7; Citations per year 1 of 5; Impact for its field and year 2 of 6; Cited by studies here 0 of 6; Still being cited 1 of 4; Senior author's track record 1 of 4; Institution's track record 0 of 3; Multi-centre collaboration 1 of 3; Indexed in PubMed 2 of 2; Free to read 2 of 2. Total 41 of 100.41 of 100 points earned59 not earned

Published in a peer-reviewed journal. Scored zero for study design and randomised / blinded because the record does not state it.

ComponentPointsWhy
Journal tier 7 / 10 Tier 3 — peer-reviewed journal (Biomedicines)
Journal's citation record 1 / 4 Biomedicines: journal h-index 133 (OpenAlex, 2026-10-29)
Study design 0 / 12 No study design recorded — scores zero, not guessed (not stated in the record — scored 0)
Strength of evidence 1 / 5 Rated “low” in our summary
Peer-review validation 10 / 10 Peer-reviewed. Published as an article in a named peer-reviewed journal.
How recent 4 / 5 2025 — within 3 year(s) of the newest study here
Sample size 2 / 4 128 participants
Effect reported 2 / 3 Effect reported as a number, without an interval or test
Studied in people 3 / 3 Studied in people (participant count stated)
Randomised / blinded 0 / 2 No randomisation or blinding stated — scores zero (not stated in the record — scored 0)
Times cited 1 / 7 Cited 3 times (OpenAlex, 2026-10-10)
Citations per year 1 / 5 1.0 citations a year over 3 year(s) since 2025
Impact for its field and year 2 / 6 Cited 1.9× the average for papers of its field and year (OpenAlex FWCI)
Cited by studies here 0 / 6 No other study in this library cites it
Still being cited 1 / 4 Cited 3 times in 2024–2026 (2026 still in progress; OpenAlex)
Senior author's track record 1 / 4 Last-listed author Zhongting Chen: h-index 13 (OpenAlex, whole career)
Institution's track record 0 / 3 East China Normal University: institution h-index 506 (OpenAlex)
Multi-centre collaboration 1 / 3 OpenAlex lists 2 institution(s) in 1 country
Indexed in PubMed 2 / 2 Indexed in PubMed (PMID 40149714)
Free to read 2 / 2 Free to read
Total 41 / 100 —

What each of these 20 components measures, and what this score is not →

Read the original

Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).

Studies this one cites

Referenced by this study and also in the alzhub library, so you can read them here.

Related studies in Getting a diagnosis

Also tagged “examination”

840 studies in the library carry the topic tag “examination”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 840 tagged studies.

Similar studies

More on Getting a diagnosis

See all studies in Getting a diagnosis →